EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
18 hedge funds and large institutions have $174M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% less capital invested
Capital invested by funds: $188M → $174M (-$13.8M)
Holders
18
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$4.27M | |
| 2 | +$594K | |
| 3 | +$430K | |
| 4 |
Morgan Stanley
New York
|
+$236K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$138K |
Top Sellers
| 1 | -$4.14M | |
| 2 | -$347K | |
| 3 | -$257K | |
| 4 |
VF
Virtu Financial
New York
|
-$245K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$187K |